Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic

Xuhao Zhao, Xiaolin Xu, Yifan Yan, Darren M. Lipnicki, Ting Pang, John D. Crawford, Christopher Chen, Ching‐Yu Cheng, Narayanaswamy Venketasubramanian, Eddie Chong, Sérgio Luís Blay, Maria Fernanda Lima-Costa, E. Costa, Richard Lipton, Mindy J. Katz, Karen Ritchie, Nikolaos Scarmeas, Mary Yannakoulia, Mary H. Kosmidis, Oye Gureje, Akin Ojagbemi, Toyin Bello, Hugh C. Hendrie, Sujuan Gao, Ricardo Oliveira Guerra, Mohammad Auais, Fernando Gómez, E Rolandi, Annalisa Davin, Michele Rossi, Steffi G. Riedel‐Heller, Margrit Löbner, Susanne Roehr, Mary Ganguli, Erin Jacobsen, Chung-Chou H. Chang, Allison E. Aiello, Roger S. Ho, Pascual Sánchez‐Juan, Meritxell Valentí, Teodoro del Ser, António Lobo, Concepción De‐la‐Cámara, Elena Lobo, Perminder S. Sachdev, Xin XuThe Lancet Regional Health - Western Pacific 2024 · DOI

Abstract

This study examines the independent and joint associations of cardiometabolic multimorbidity (CMM) and depression with cognitive function in older adults. Utilizing pooled individual participant data from 14 international cohorts ($N > 30,000$), we found that while CMM and depression do not interact synergistically, their additive effects significantly accelerate cognitive decline. These findings are consistent across global regions and generalize from community to clinical settings, emphasizing the need for integrated management of physical and mental health to preserve cognitive longevity.

Introduction

As the global population ages, dementia has emerged as a primary public health challenge. While researchers have long identified individual risk factors like diabetes or depression, real-world patients rarely present with a single chronic condition. Multimorbidity—the co-occurrence of multiple chronic conditions—is the rule rather than the exception in older age.

This research addresses a critical gap: how physical cardiometabolic clusters (such as hypertension, diabetes, and heart disease) and mental health (depression) work together to influence the brain. Furthermore, the study seeks to determine if these associations hold true across diverse ethnicities and different healthcare settings, ranging from general communities to specialized memory clinics.

Methods

The researchers utilized a pooled individual participant data (IPD) analysis, harmonizing raw data from 14 longitudinal cohorts within the Cohort Studies of Memory in an International Consortium (COSMIC). This approach is more robust than standard meta-analysis as it involves re-analyzing standardized data rather than aggregating published results.

Definitions and Scoring

Two definitions of CMM were tested:

  • CMM5: Presence of $\ge$ 2 conditions among hypertension, hyperlipidemia, diabetes, stroke, and heart disease.
  • CMM3: Presence of $\ge$ 2 conditions among diabetes, stroke, and heart disease (a stricter definition reflecting higher disease severity).

Global cognition was standardized into z-scores to allow comparison across different neuropsychological tests used globally.

Validation

To ensure generalizability, findings were validated using three external Asian cohorts representing a spectrum of care: the Singapore Epidemiology of Eye Diseases study (Community), a Singapore memory clinic study (Clinical), and the COgnition After STroke (COAST) cohort (Clinical/Post-stroke).

Results

Independent and Additive Effects

A key finding is that CMM and depression are independently associated with cognitive decline. No significant statistical interaction (synergy) was found, meaning depression does not specifically worsen the cognitive impact of diabetes or heart disease. Instead, the joint association is additive; participants with both conditions showed the poorest cognitive performance and the steepest decline over time.

Quantitative Findings

  • Cross-sectional: Participants with both CMM5 and depression had significantly lower cognitive z-scores ($\beta = -0.207$) compared to healthy controls.
  • Longitudinal: Those with both conditions experienced a faster annual rate of cognitive decline ($\beta = -0.040$).
  • Severity: CMM3 was associated with a stronger negative impact on baseline cognition than CMM5, likely reflecting the higher severity of its constituent diseases compared to "silent" risks like hypertension.

Interaction analyses suggested that the association between CMM/depression and cognitive decline might be more pronounced in females and in individuals residing in high-income countries (HICs) compared to lower-middle-income countries (LMICs).

Discussion

The consistency of these findings across global regions and clinical settings suggests a fundamental biological relationship between cardiometabolic health, mental health, and neurocognition. The inclusion of metabolic risks like hypertension in the CMM5 definition tripled the observed prevalence of multimorbidity, highlighting the importance of early intervention.

Limitations

The study relies on some self-reported diagnoses, which may lead to underestimation. Additionally, the observational design cannot definitively rule out reverse causation, where early cognitive impairment leads to depressive symptoms. The absence of brain imaging or biomarkers limits the ability to clarify specific underlying pathologies, such as vascular damage versus Alzheimer’s disease.

Conclusion

Future interventions should move away from single-disease models and instead target both cardiometabolic and psychological health simultaneously to protect the aging brain. Integrated care strategies are essential to mitigate the cumulative burden of multimorbidity on cognitive health.

Summary updated

Abstract

Natural Science Foundation of China and National Institute on Aging/National Institutes of Health.
BibTeX
@inproceedings{zhao2024independent,
  author = {Xuhao Zhao and Xiaolin Xu and Yifan Yan and Darren M. Lipnicki and Ting Pang and John D. Crawford and Christopher Chen and Ching‐Yu Cheng and Narayanaswamy Venketasubramanian and Eddie Chong and Sérgio Luís Blay and Maria Fernanda Lima-Costa and E. Costa and Richard Lipton and Mindy J. Katz and Karen Ritchie and Nikolaos Scarmeas and Mary Yannakoulia and Mary H. Kosmidis and Oye Gureje and Akin Ojagbemi and Toyin Bello and Hugh C. Hendrie and Sujuan Gao and Ricardo Oliveira Guerra and Mohammad Auais and Fernando Gómez and E Rolandi and Annalisa Davin and Michele Rossi and Steffi G. Riedel‐Heller and Margrit Löbner and Susanne Roehr and Mary Ganguli and Erin Jacobsen and Chung-Chou H. Chang and Allison E. Aiello and Roger S. Ho and Pascual Sánchez‐Juan and Meritxell Valentí and Teodoro del Ser and António Lobo and Concepción De‐la‐Cámara and Elena Lobo and Perminder S. Sachdev and Xin Xu},
  title = {{Independent and joint associations of cardiometabolic multimorbidity and depression on cognitive function: findings from multi-regional cohorts and generalisation from community to clinic}},
  booktitle = {The Lancet Regional Health - Western Pacific},
  year = {2024},
  doi = {10.1016/j.lanwpc.2024.101198},
}
Figure